Bravecto 250 mg (Fluralaner SOLUTION) 250 MG

Bravecto 250 mg is a topical solution containing fluralaner, designed for effective parasite control in pets. This solution offers long-lasting protection against fleas and ticks, ensuring your pet's comfort and health.

Strength

250 MG

Manufacturer / TM Owner

INTERVET CANADA CORP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bravecto 250 mg is primarily used for the treatment and prevention of flea and tick infestations in pets. It is a topical solution that provides extended protection, making it a convenient choice for pet owners. The active ingredient, fluralaner, works by disrupting the nervous system of parasites, effectively eliminating them. This solution is suitable for pets that require reliable and long-term parasite control.

Side Effects

Bravecto 250 mg is applied topically and begins to work by spreading across the pet's skin and coat. It targets fleas and ticks, disrupting their nervous system to eliminate them. Some pets may experience mild irritation at the application site, but this is typically temporary. The solution is designed to provide long-lasting protection, reducing the need for frequent treatments.

Precautions & Warnings

When using Bravecto 250 mg, it is important to follow the instructions provided by your veterinarian. Ensure the solution is applied to dry skin and avoid contact with the pet's eyes. Keep the pet away from water for a few hours after application to allow the solution to fully absorb. Store the product in a cool, dry place away from children and other pets.

Avoid Interactions

Bravecto 250 mg is generally safe for use in pets, but it is important to inform your veterinarian about any other medications your pet is taking. Some medications may interact with fluralaner, so it is crucial to discuss potential interactions with a healthcare professional. Avoid using other flea and tick treatments simultaneously unless directed by a veterinarian.

Frequently Asked Questions

Bravecto 250 mg is used for the treatment and prevention of flea and tick infestations in pets. It provides long-lasting protection against these parasites.

The frequency of application depends on your pet's specific needs and the recommendations of your veterinarian. Typically, it is applied every 12 weeks.

Bravecto 250 mg is generally safe for use in puppies, but it is important to consult your veterinarian to determine the appropriate dosage and usage.

If your pet shows signs of irritation, such as redness or itching, rinse the area with water and consult your veterinarian for further guidance.

Bravecto 250 mg is specifically formulated for dogs. It should not be used on cats unless directed by a veterinarian.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.